Page last updated: 2024-08-23

etoposide and vitamin u

etoposide has been researched along with vitamin u in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Depatie, C; Hayakawa, J; Mercola, D; Ohmichi, M	1

Other Studies

1 other study(ies) available for etoposide and vitamin u

Article	Year
The activation of c-Jun NH2-terminal kinase (JNK) by DNA-damaging agents serves to promote drug resistance via activating transcription factor 2 (ATF2)-dependent enhanced DNA repair. The Journal of biological chemistry, 2003, Jun-06, Volume: 278, Issue:23 Topics: Activating Transcription Factor 2; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cisplatin; Cyclic AMP Response Element-Binding Protein; Dactinomycin; DNA Damage; DNA Repair; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Gastrointestinal Agents; Humans; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; Phenotype; Transcription Factors; Transcriptional Activation; Tumor Cells, Cultured; Vitamin U	2003

Article

Year

The activation of c-Jun NH2-terminal kinase (JNK) by DNA-damaging agents serves to promote drug resistance via activating transcription factor 2 (ATF2)-dependent enhanced DNA repair.

The Journal of biological chemistry, 2003, Jun-06, Volume: 278, Issue:23

Topics: Activating Transcription Factor 2; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cisplatin; Cyclic AMP Response Element-Binding Protein; Dactinomycin; DNA Damage; DNA Repair; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Gastrointestinal Agents; Humans; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; Phenotype; Transcription Factors; Transcriptional Activation; Tumor Cells, Cultured; Vitamin U

2003